Page last updated: 2024-09-03

5-fluoro-2,2'-cyclocytidine and thioguanine anhydrous

5-fluoro-2,2'-cyclocytidine has been researched along with thioguanine anhydrous in 1 studies

Compound Research Comparison

Studies
(5-fluoro-2,2'-cyclocytidine)
Trials
(5-fluoro-2,2'-cyclocytidine)
Recent Studies (post-2010)
(5-fluoro-2,2'-cyclocytidine)
Studies
(thioguanine anhydrous)
Trials
(thioguanine anhydrous)
Recent Studies (post-2010) (thioguanine anhydrous)
5102,706295389

Protein Interaction Comparison

ProteinTaxonomy5-fluoro-2,2'-cyclocytidine (IC50)thioguanine anhydrous (IC50)
Replicase polyprotein 1abSevere acute respiratory syndrome coronavirus 20.5333
Prostaglandin G/H synthase 1Homo sapiens (human)0.601
Mitogen-activated protein kinase 3 Homo sapiens (human)5.516

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Arlin, Z; Burchenal, JH; Clarkson, B; Comacho, E; Dowling, M; Drapkin, RL; Dufour, P; Gee, TS; Kempin, S; McKenzie, S; Mertelsmann, R; Oettgen, HF; Passe, S; Thaler, HT; To, L1

Trials

1 trial(s) available for 5-fluoro-2,2'-cyclocytidine and thioguanine anhydrous

ArticleYear
Treatment of acute nonlymphocytic leukemia in adults: response to 2,2-anhydro-1-B-D-arabinofuranosyl-5-fluorocytosine and thioguanine on the L-12 protocol.
    Cancer, 1981, Nov-15, Volume: 48, Issue:10

    Topics: Adolescent; Adult; Aged; Ancitabine; Antineoplastic Agents; Bacterial Vaccines; Cytarabine; Drug Therapy, Combination; Female; Humans; Leukemia; Leukemia, Myeloid, Acute; Male; Middle Aged; Prognosis; Pseudomonas aeruginosa; Random Allocation; Thioguanine

1981